Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow

Background: Coronary slow flow (CSF) is a common cardiovascular phenomenon with no effective treatment in conventional Western medicine (CWM). Shexiang Baoxin Pill (SXBXP) is a widely used Chinese medicine for cardiovascular disease in China, and clinical studies have shown that it has good efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hongxin, Li, Xingyuan, Zhu, Mingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441803/
https://www.ncbi.nlm.nih.gov/pubmed/36071856
http://dx.doi.org/10.3389/fphar.2022.955146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441803/
https://www.ncbi.nlm.nih.gov/pubmed/36071856
http://dx.doi.org/10.3389/fphar.2022.955146

Ejemplares similares